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The Editorial on the Research Topic
Adrenal cortex: from physiology to disease
The adrenal gland plays essential roles in the control of body homeostasis, stress, and immune 
responses. The adrenal cortex represents up to 90% of the gland and is specialized in the production 
of adrenal steroids. The coordinate production of these steroids relies on adrenal cortex zonation, 
which corresponds to the establishment of distinct concentric functional zones in the perinatal 
period: outermost zona glomerulosa synthesizes mineralocorticoids, zona fasciculata produces 
glucocorticoids, and innermost zona reticularis synthesizes both glucocorticoids and adrenal 
androgens.
This zonal organization has to be maintained throughout the life of the individual, despite con-
stant centripetal tissue renewal. The review by Pihlajoki et al. summarizes the latest findings on the 
mechanisms of adrenal cortex renewal, which relies on outer cortex progenitors recruitment and 
lineage conversion along cell migration within the cortex. This paper also provides a comprehensive 
overview of the hormones, signaling pathways, and transcription factors that control these processes 
to allow for on-demand adaptation of cortical function and maintenance of adrenal homeostasis.
Defects in adrenal development and maintenance are associated with adrenal insufficiency, a 
life threatening condition for which lifelong hormonal replacement therapies can be challenging. 
The review by Ruiz-Babot and colleagues sheds light on novel developments in the field of adrenal 
replacement, including pluripotent cell reprograming and the use of encapsulating devices with 
semi-permeable membranes to avoid immune rejection of grafts. These promising approaches could 
pave the way for future clinical management of adrenal-insufficiency patients.
While adrenal insufficiency is clinically problematic, the opposite situation in which adrenal 
steroid production is increased also raises significant clinical concerns. Hypercortisolism results 
in Cushing’s syndrome associated with central obesity, arterial hypertension, immunosuppression, 
and depression. Hyperaldosteronism is associated with high blood pressure and profound cardio-
vascular and renal alterations, which result in increased risk of cardiovascular failure. These highly 
morbid syndromes are the consequence of either benign hyperplasia and tumors or adrenocortical 
cancer (ACC).
The review by Boulkroun and colleagues establishes the molecular bases of normal control of 
aldosterone production and elaborates on recent next-generation sequencing (NGS) analyses that 
allowed identification of mutations in potassium and calcium channels as key players in the develop-
ment of hyperaldosteronism. Even if these mutations can explain increased aldosterone secretion, 
they are unlikely to account for tumor growth. Boulkroun et  al. summarize data showing that 
deregulated cell growth in aldosterone-producing adenomas is likely to result from WNT and SHH 
signaling pathway activation in these tumors.
Deregulated protein kinase A (PKA) signaling is a common theme in adrenal tumors associated 
with ACTH-independent hypercortisolism. These include primary pigmented adrenocortical disease 
(PPNAD), adrenal adenomas, bilateral macronodular adrenal hyperplasia (BMAH), and adrenal 
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cancer. The review by Berthon et al. provides in-depth insight into 
the genetic causes of deregulated PKA signaling, including inac-
tivating PRKAR1A mutations in PPNAD and activating PRKACA 
mutations in cortisol-producing adenomas. Interestingly, muta-
tions in either PRKAR1A or PRKACA were not found in BMAH. 
The review by Drougat et al. emphasizes the discovery of muta-
tions in ARMC5 as a likely cause of these particular benign adrenal 
tumors and elaborates on potential pathogenic mechanisms. 
Lefebvre et al. shed another light on BMAH by focusing on the 
paracrine regulation of cortisol secretion. They gather data show-
ing that cortisol secretion is stimulated by the release of a number 
of factors either produced by non-steroidogenic cells within the 
cortex (mast, chromaffin, and endothelial cells) or by a subset of 
aberrantly differentiated steroidogenic cells that can release sero-
tonin or even ACTH within the hyperplastic tissue. They further 
suggest that aberrant ACTH production and expression of ectopic 
receptors, such as the receptors of LH, GIP, and 5-HT7, may be the 
result of aberrant differentiation of gonadal-like cells, triggered by 
driver mutations, such as ARMC5 inactivation.
Beyond steroid hormone excess, which is also observed in 
about 40–60% of patients, ACC still represents a major thera-
peutic challenge. The review by Libé and colleagues provides 
an overview of current diagnosis and treatment of ACC, which 
emphasizes the need for novel therapeutic targets in a cancer 
with dismal prognosis. The review by Drougat and colleagues 
provides insight into the role of mutations targeting the WNT 
signaling pathway (essentially activating mutations of CTNNB1 
and deletions of ZNRF3) and their pathogenic role in ACC. 
This paper on adult ACC is nicely complemented by Lalli and 
Figueiredo’s review that focuses on pediatric ACC. These are 
rare tumors that generally occur in the context of TP53 altera-
tions, in particular the specific R337H mutation found with high 
frequency in Southern Brazil. The authors present evidence that 
these tumors are likely to derive from the fetal adrenal and dis-
cuss the common and divergent alterations found in pediatric 
and adult ACC, which highlights the lack of effective prognosis 
markers in the former. Deregulation of miRNA production is 
a common theme in most cancers. Nadia Cherradi provides a 
comprehensive overview of miRNA deregulation in ACC and 
shows that they can provide novel insight into the pathogenesis 
of ACC and may constitute interesting therapeutic targets. This 
review also highlights the usefulness of circulating miRNAs as 
novel non-invasive diagnostic and prognostic biomarkers in 
ACC. It further elaborates on an exciting aspect of miRNAs 
biology that involves their circulation within ACC cell-derived 
exosomes, which would allow communication with tumor 
microenvironment.
We hope that you will find this topic inspiring and that it will 
shed light on exciting aspects of adrenal physiology and disease.
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